ZERBAXA (Merck Sharp & Dohme Corp.)
Welcome to the PulseAid listing for the ZERBAXA drug offered from Merck Sharp & Dohme Corp.. This Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | Merck Sharp & Dohme Corp. |
| NON-PROPRIETARY NAME: | ceftolozane and tazobactam |
| SUBSTANCE NAME: | CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Cephalosporin Antibacterial [EPC],Cephalosporins [Chemical/Ingredient],beta Lactamase Inhibitor [EPC],beta Lactamase Inhibitors [MoA] |
| ROUTE: | INTRAVENOUS |
| DOSAGE FORM: | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
| MARKETING CATEGORY NAME: | NDA |
| START MARKETING DATE: | 2014-12-19 |
| END MARKETING DATE: | 0000-00-00 |
ZERBAXA HUMAN PRESCRIPTION DRUG Details:
| Item Description | ZERBAXA from Merck Sharp & Dohme Corp. |
| LABELER NAME: | Merck Sharp & Dohme Corp. |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 1; .5(g/10mL; g/10mL) |
| START MARKETING DATE: | 2014-12-19 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 67919-030_63e258f2-8cb7-4346-aef4-a1df551aa3fa |
| PRODUCT NDC: | 67919-030 |
| APPLICATION NUMBER: | NDA206829 |
Other CEFTOLOZANE SULFATE; TAZOBACTAM SODIUM Pharmaceutical Manufacturers / Labelers:
